跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL
Approved
STANDARD
MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 9, 2024
Approval ID
cb810f312ecb85e1
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
cb810f312ecb85e1
Drug Cima Aemps Name
MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL
Register Number
1221685025
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Lilly S.A.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Marketing Company Detail Path
/organization/lilly-sa
Authorization Date
2024-02-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
2,5 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
TIRZEPATIDA
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 9, 2024
Approval ID
cb810f312ecb85e1
Type
Standard
Back to CIMA-AEMPS Approvals
